This included positive associations between losses in 1p36.32, 3p26.2, 4q35.2, 7p22.3 and 18q23 with the expression of the cancer-related genes CDKN11B, CRBN, IRF2, PRKAR1B and NFATC. This evidence concerns the gene NFATC1 and cancer.